Shanghai Titan Scientific Co.,Ltd.

Shanghai Stock Exchange 688133.SS

Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 393.06 M

Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity is USD 393.06 M for the year ending December 31, 2023, a -0.27% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 394.11 M, a 58.90% change year over year.
Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 248.03 M, a 12.59% change year over year.
Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 220.31 M, a 172.20% change year over year.
Shanghai Titan Scientific Co.,Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 80.94 M, a 44.15% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shanghai Stock Exchange: 688133.SS

Shanghai Titan Scientific Co.,Ltd.

CEO	Mr. Qing Zhang
IPO Date	Oct. 30, 2020
Location	China
Headquarters	No. 89, Shilong Road
Employees	1,637
Sector	Materials
Industries Chemicals & Advanced Materials Biotechnology Research & Consulting

Description

Shanghai Titan Scientific Co., Ltd. provides laboratory products and supporting services for scientific researchers and quality control personnel. It offers a range of services for laboratories in the fields of biomedicine, new materials, new energy, chemical chemistry, fine chemicals, food daily chemicals, analysis, and testing through independent research and development, brand operation, brand agency, integrated packaging services, etc. Shanghai Titan Scientific Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Key trends

Past 5 years